Abstract |
[11C]5-hydroxy- tryptophan ([11C]5-HTP) positron emission tomography of the pancreas has been shown to be a surrogate imaging biomarker of pancreatic islet mass. The change in islet mass in different stages of type 2 diabetes (T2D) as measured by noninvasive imaging is currently unknown. Here, we describe a cross-sectional study where subjects at different stages of T2D development with expected stratification of pancreatic islet mass were examined in relation to individuals without diabetes. The primary outcome was the [11C]5-HTP uptake and retention in pancreas, as a surrogate marker for the endogenous islet mass. We found that metabolic testing indicated a progressive loss of β-cell function, but this was not mirrored by a decrease in [11C]5-HTP tracer accumulation in the pancreas. This provides evidence of retained islet mass despite decreased β-cell function. The results herein indicate that β-cell dedifferentiation, and not necessarily endocrine cell loss, constitutes a major cause of β-cell failure in T2D.
|
Authors | Lina Carlbom, Daniel Espes, Mark Lubberink, Mats Martinell, Lars Johansson, Håkan Ahlström, Per-Ola Carlsson, Olle Korsgren, Olof Eriksson |
Journal | Diabetes
(Diabetes)
Vol. 66
Issue 5
Pg. 1286-1292
(05 2017)
ISSN: 1939-327X [Electronic] United States |
PMID | 28246291
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017 by the American Diabetes Association. |
Chemical References |
- Blood Glucose
- C-Peptide
- Carbon Radioisotopes
- Hypoglycemic Agents
- Insulin
- Arginine
- 5-Hydroxytryptophan
- Glucose
|
Topics |
- 5-Hydroxytryptophan
- Aged
- Arginine
- Blood Glucose
(metabolism)
- C-Peptide
(blood)
- Carbon Radioisotopes
- Case-Control Studies
- Cell Differentiation
- Cross-Sectional Studies
- Diabetes Mellitus, Type 2
(diagnostic imaging, drug therapy, metabolism, pathology)
- Disease Progression
- Female
- Glucose
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Insulin
(therapeutic use)
- Insulin-Secreting Cells
(metabolism, pathology)
- Islets of Langerhans
(diagnostic imaging, metabolism, pathology)
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Organ Size
- Positron Emission Tomography Computed Tomography
|